Therapeutic advances in melanoma.

Therapy for melanoma continues to evolve, and with the expanding work in the basic pathophysiology, the continued development of biologic modifiers is expected. With new treatment regimens, the rate of remissions is improving for patients with metastatic disease. Much work has yet to be done, however, and there will be continued development in all areas.